Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
280,555,433
-
Share change
-
+4,557,275
-
Total reported value
-
$11,729,766,613
-
Put/Call ratio
-
39%
-
Price per share
-
$41.79
-
Number of holders
-
837
-
Value change
-
+$201,281,853
-
Number of buys
-
400
-
Number of sells
-
315
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q1 2019
As of 31 Mar 2019,
GLAXOSMITHKLINE PLC - ADR (GSK) was held by
837 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
280,555,433 shares.
The largest 10 holders included
DODGE & COX, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, RENAISSANCE TECHNOLOGIES LLC, ROYAL BANK OF CANADA, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, STATE STREET CORP, BANK OF AMERICA CORP /DE/, and Black Creek Investment Management Inc..
This page lists
837
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.